Daiwa Securities Group
CGON icon

Daiwa Securities Group’s CG Oncology CGON Stock Holding History

Daiwa Securities Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-239
Closed -$10K – 1236
2025
Q4 		$10K Buy
239
+5
+2% +$207 ﹤0.01% 1185
2025
Q3 		$9K Sell
234
-40
-15% -$1.16K ﹤0.01% 1161
2025
Q2 		$7K Buy
274
+51
+23% +$1.23K ﹤0.01% 1132
2025
Q1 		$5K Hold
223
– – ﹤0.01% 1130
2024
Q4 		$6K Buy
+223
New +$7.63K ﹤0.01% 1151

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Daiwa Securities Group's CGON Position: Q1 2026 in Review

Daiwa Securities Group sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 239 shares — an estimated $10K sold.

Daiwa Securities Group first reported a position in CGON in Q4 2024 and held it in 5 quarters. The position peaked at $10K in Q4 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Daiwa Securities Group reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 239 CG Oncology shares in Q1 2026, an estimated $10K.
  • Daiwa Securities Group first reported a position in CG Oncology in Q4 2024 and held it in 5 quarters.
  • Daiwa Securities Group's CG Oncology position peaked at $10K in Q4 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.